UK Scientists Launch Synthetic Human Genome Project with £10 Million Funding
Five-year initiative aims to construct human DNA from scratch to advance medical research and understanding of genetic functions
Researchers in the United Kingdom have initiated the Synthetic Human Genome (SynHG) project, a five-year endeavor funded with ten million pounds by the Wellcome Trust.
The project seeks to synthesize human DNA from basic chemical components, marking a significant step in synthetic biology.
Led by Professor Jason Chin at the Medical Research Council's Laboratory of Molecular Biology in Cambridge, the SynHG project involves collaboration among several UK institutions, including the universities of Cambridge, Oxford, Manchester, Kent, and Imperial College London.
The initial objective is to construct a single human chromosome synthetically, providing insights into genetic functions and potential therapeutic applications.
The project builds upon previous successes in synthesizing genomes of simpler organisms, such as the E.
coli bacterium.
However, the human genome's complexity, encompassing over three billion base pairs, presents substantial challenges.
Advances in artificial intelligence and data science are expected to play a crucial role in overcoming these obstacles.
Potential applications of synthetic human DNA include the development of disease-resistant cells and novel treatments for various conditions.
For instance, creating synthetic mitochondria could help prevent the transmission of certain inherited disorders.
Additionally, understanding the so-called "dark matter" of the genome—non-coding regions with unknown functions—may lead to breakthroughs in medical science.
Recognizing the ethical implications of synthesizing human DNA, the project incorporates a dedicated ethics component.
Professor Joy Zhang from the University of Kent leads a team examining the moral, legal, and societal aspects of genome synthesis.
Concerns addressed include the potential for creating "designer babies" and the environmental risks associated with engineered organisms.
The SynHG project represents a continuation of the United Kingdom's prominent role in genomic research, following its significant contributions to the Human Genome Project completed in two thousand and three.
By exploring the possibilities of constructing human DNA synthetically, researchers aim to deepen the understanding of genetic mechanisms and pave the way for innovative medical therapies.
The project seeks to synthesize human DNA from basic chemical components, marking a significant step in synthetic biology.
Led by Professor Jason Chin at the Medical Research Council's Laboratory of Molecular Biology in Cambridge, the SynHG project involves collaboration among several UK institutions, including the universities of Cambridge, Oxford, Manchester, Kent, and Imperial College London.
The initial objective is to construct a single human chromosome synthetically, providing insights into genetic functions and potential therapeutic applications.
The project builds upon previous successes in synthesizing genomes of simpler organisms, such as the E.
coli bacterium.
However, the human genome's complexity, encompassing over three billion base pairs, presents substantial challenges.
Advances in artificial intelligence and data science are expected to play a crucial role in overcoming these obstacles.
Potential applications of synthetic human DNA include the development of disease-resistant cells and novel treatments for various conditions.
For instance, creating synthetic mitochondria could help prevent the transmission of certain inherited disorders.
Additionally, understanding the so-called "dark matter" of the genome—non-coding regions with unknown functions—may lead to breakthroughs in medical science.
Recognizing the ethical implications of synthesizing human DNA, the project incorporates a dedicated ethics component.
Professor Joy Zhang from the University of Kent leads a team examining the moral, legal, and societal aspects of genome synthesis.
Concerns addressed include the potential for creating "designer babies" and the environmental risks associated with engineered organisms.
The SynHG project represents a continuation of the United Kingdom's prominent role in genomic research, following its significant contributions to the Human Genome Project completed in two thousand and three.
By exploring the possibilities of constructing human DNA synthetically, researchers aim to deepen the understanding of genetic mechanisms and pave the way for innovative medical therapies.
